Hua‐Jay J. Cherng

机构：Columbia University Irving Medical Center · ORCID：0000-0002-8266-8447

发表论文 69 篇 · 总被引 303 次 · h-index 10

代表论文

• Remission Assessment by Circulating Tumor DNA in Large B-Cell Lymphoma (2025 · Journal of Clinical Oncology · 被引 32)
• Treatment-related outcomes and patterns of relapse in secondary CNS involvement by large B-cell lymphoma (2026 · Blood · 被引 6)
• Implementing Financial Screening for Adolescents and Young Adults Treated in the Outpatient Oncology Setting (2025 · JCO Oncology Practice · 被引 6)
• Cell-of-Origin Subtype Predicts Response to Polatuzumab Vedotin in Large B-cell Lymphoma (2025 · Clinical Cancer Research · 被引 3)
• 289 | MULTICENTER REAL‐WORLD OUTCOMES OF FRONTLINE POLA‐R‐CHP IN TREATMENT NAÏVE DLBCL (2025 · Hematological Oncology · 被引 3)
• Sequencing-guided chemotherapy optimization using real-time evaluation in newly diagnosed DLBCL with circulating tumor DNA: SHORTEN-ctDNA (NCT06693830). (2025 · Journal of Clinical Oncology · 被引 3)